Invasive Pulmonary Aspergillosis After Solid Organ Transplantation: Diagnosis and Treatment Based on 28 Years of Transplantation Experience

Transplantation Proceedings

Volumn 41, Issue 1, 2009, Pages 375-378

  Ju, M K ^a   Joo, D J ^a   Kim, S J ^a   Chang, H K ^a   Kim, M S ^a   Kim, S I ^a   Kim, Y S ^a  

^a Yonsei University College of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; ANTIFUNGAL AGENT; BASILIXIMAB; CALCINEURIN INHIBITOR; CASPOFUNGIN; CYCLOSPORIN; FLUCONAZOLE; IMMUNOSUPPRESSIVE AGENT; INTERLEUKIN 2 RECEPTOR ANTIBODY; LYMPHOCYTE ANTIBODY; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; STEROID; TACROLIMUS; THYMOCYTE ANTIBODY; VORICONAZOLE;

ADULT; ARTICLE; AUTOPSY; DISEASE COURSE; EARLY DIAGNOSIS; ELECTROLYTE DISTURBANCE; FEMALE; GRAFT REJECTION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INCIDENCE; KIDNEY TRANSPLANTATION; LIVER TRANSPLANTATION; LUNG ASPERGILLOSIS; MAJOR CLINICAL STUDY; MALE; MORTALITY; NEPHROTOXICITY; ORGAN TRANSPLANTATION; PRIORITY JOURNAL; SPUTUM CULTURE; THORAX RADIOGRAPHY; TRANSBRONCHIAL BIOPSY;

ADULT; ANTIFUNGAL AGENTS; DISEASE PROGRESSION; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY TRANSPLANTATION; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; PULMONARY ASPERGILLOSIS; RADIOGRAPHY, THORACIC; REOPERATION; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; SURVIVORS;

EID: 60649104667     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transproceed.2008.11.006     Document Type: Article

References (23)

1. Schmidt A., and Oberbauer R. Bacterial and fungal infections after kidney transplantation. Curr Opin Urol 9 (1999) 45
2. Abbott K.C., Hypolite I.O., Viola R., et al. Hospitalizations for fungal infections after renal transplantation in the United States. Transpl Infect Dis 3 (2001) 203
3. Veroux M., Macarone M., Fiamingo P., et al. Caspofungin in the treatment of azole-refractory esophageal candidiasis in kidney transplant recipients. Transplant Proc 38 (2006) 1037
4. Wajszczuk C.P., Dummer J.S., Ho M., et al. Fungal infection in liver transplant recipients. Transplantation 40 (1985) 347
5. Chugh K.S., Sakhuja V., Jain S., et al. High mortality in systemic fungal infections following renal transplantation in third-world countries. Nephrol Dial Transplant 8 (1993) 168
6. Weiland D., Ferguson R.M., Peterson P.K., et al. Aspergillosis in 25 renal transplant patients: epidemiology, clinical presentation, diagnosis and management. Ann Surg 198 (1983) 622
7. Lin S.-J., Schranz J., and Teutsch S.M. Aspergillosis case-fatality: systematic review of the literature. Clin Infect Dis 32 (2001) 358
8. Paterson D.L., and Singh N. Invasive aspergillosis in transplant recipients. Medicine 78 (1999) 123
9. Kawakami N., Nishizaki T., Sugiyama S., et al. Aspergillus brain abscess in a patient with normal immunity-case report. Neurol Med Chir 34 (1999) 237
10. Harari S. Current strategies in the treatment of invasive Aspergillus infections in immunocompromised patients. Drugs 58 (1999) 621
11. Ascioglu S., Rex J.H., de Pauw B., et al. Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: an international consensus. Clin Infect Dis 34 (2002) 7
12. Iemmolo R.M., Rossanese A., Rotilio A., et al. Cerebral aspergillosis in a liver transplant recipient: a case report of long-term survival after combined treatment with liposomal amphotericin B and surgery. J Hepatol 28 (1998) 518
13. Saraceno J.L., Phelps D.T., Ferro T.J., et al. Chronic necrotizing pulmonary aspergillosis: approach to management. Chest 112 (1997) 541
14. Singh N., and Paterson D.L. Aspergillus infections in transplant recipients. Clin Microbiol Rev 18 (2005) 44
15. Kusne S., Torre-Cisneros J., Mañez R., et al. Factors associated with invasive lung aspergillosis and the significance of positive Aspergillus culture after liver transplantation. J Infect Dis 166 (1999) 1379
16. Caillot D., Casasnovas O., Bernard A., et al. Improved management of invasive pulmonary aspergillosis in neutropenic patients using early thoracic computed tomographic scan and surgery. J Clin Oncol 15 (1997) 139
17. Busca A., Locatelli F., Barbui A., et al. Usefulness of sequential Aspergillus galactomannan antigen detection combined with early radiologic evaluation for diagnosis of invasive pulmonary aspergillosis in patients undergoing allogeneic stem cell transplantation. Transplant Proc 38 (2006) 1610
18. Lee T.Y., Yang S.S., Chen G.H., et al. Hepatic abscess caused by Aspergillus fumigatus infection following splenectomy and immunosuppressive therapy. J Formos Med Assoc 102 (2003) 501
19. Herbrecht R., Denning D.W., Patterson T.F., et al. Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis. N Engl J Med 347 (2002) 408
20. Fortún J., Martín-Dávila P., Sánchez M.A., et al. Voriconazole in the treatment of invasive mold infection in transplant recipients. Eur J Clin Microbiol Infect Dis 22 (2003) 408
21. Tintillier M., Kirch L., Goffin E., et al. Interaction between voriconazole and tacrolimus in a kidney-transplanted patient. Nephrol Dial Transplant 20 (2005) 664
22. Denning D.W., Ribaud P., Milpied N., et al. Efficacy and safety of voriconazole in the treatment of acute invasive aspergillosis. Clin Infect Dis 34 (2002) 563
23. Petrovic J., Ngai A., Bradshaw S., et al. Efficacy and safety of caspofungin in solid organ transplant recipients. Transplant Proc 39 (2007) 3117